🔗 Permalink

Inventor profile of:

Normand Blais

City:

Laval

Country:

Canada

Published Applications:

Last publication date:

2020-10-22

Top Assignees for applications by Normand Blais

The entities that hold a legal rights for patent applications filed by inventor Blais Normand:

GlaxoSmithKline Biologicals S.A. 22 Rixensart, Belgium
GLAXO GROUP LIMITED 1 Greenford, Middlesex, United Kingdom
Biomedical Corporation of Quebec 1 Quebec, Canada
GLAXOSMITHKLINE 1 RIXENSART, Belgium

Recent patent applications by Blais Normand

Normand Blais from Laval, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2020-10-22

US20200331972A1

Chemistry; metallurgy

Fusion proteins and combination vaccines comprising Protein E and Pilin A

#2 | 2020-10-15

US20200325184A1

Chemistry; metallurgy

UspA2 protein constructs and uses thereof

#3 | 2019-10-24

US20190322708A1

Chemistry; metallurgy

EXPRESSION SYSTEM

#4 | 2018-12-13

US20180354996A1

Chemistry; metallurgy

UspA2 protein constructs and uses thereof

#5 | 2018-09-13

US20180258146A1

Chemistry; metallurgy

EXPRESSION SYSTEM

#6 | 2018-08-09

US20180222946A1

Chemistry; metallurgy

Fusion proteins and combination vaccines comprising haemophilus influenzae Protein E and Pilin A

#7 | 2017-05-18

US20170137475A1

Chemistry; metallurgy

Expression system

#8 | 2017-02-02

US20170029472A1

Chemistry; metallurgy

Fusion proteins and combination vaccines comprising protein E and pilin A

#9 | 2017-01-12

US20170008932A1

Chemistry; metallurgy

UspA2 protein constructs and uses thereof

#10 | 2016-09-01

US20160250313A1

Human necessities

Fusion proteins and combination vaccines comprising Protein E and Pilin A

#11 | 2016-05-05

US20160122398A1

Chemistry; metallurgy

RECOMBINANT RSV ANTIGENS

#12 | 2015-06-25

US20150175670A1

Chemistry; metallurgy

Fusion proteins and combination vaccines comprising Protein E and Pilin A

#13 | 2015-06-18

US20150166613A1

Chemistry; metallurgy

Fusion proteins and combination vaccines comprising Protein E and Pilin A

#14 | 2015-06-18

US20150166610A1

Chemistry; metallurgy

RECOMBINANT RSV ANTIGENS

#15 | 2015-04-02

US20150093414A1

Chemistry; metallurgy

Modified antigens

#16 | 2014-02-27

US20140056934A1

Chemistry; metallurgy

Fusion proteins and combination vaccines comprising Protein E and Pilin A

#17 | 2013-08-29

US20130224266A1

Human necessities

Immunogenic composition

#18 | 2013-08-22

US20130216613A1

Human necessities

CYTOMEGALOVIRUS GB ANTIGEN

#19 | 2013-05-16

US20130123472A1

Chemistry; metallurgy

MAGE antigen binding proteins

#20 | 2012-11-22

US20120294882A1

Chemistry; metallurgy

Modified tuberculosis antigens

#21 | 2012-11-15

US20120289688A1

Chemistry; metallurgy

Expression system

#22 | 2012-05-31

US20120135028A1

Human necessities

Vaccine

#23 | 2012-04-19

US20120093847A1

Human necessities

Recombinant RSV vaccines

#24 | 2012-03-22

US20120070491A1

Human necessities

CASB7439 constructs

#25 | 2011-07-21

US20110177117A1

Chemistry; metallurgy

CHIMERIC RESPIRATORY SYNCYTIAL VIRUS POLYPEPTIDE ANTIGENS

#26 | 2010-11-18

US20100291147A1

Chemistry; metallurgy

Recombinant RSV antigens

#27 | 2008-08-07

US20080187535A1

Human necessities

VACCINE

InventorID:

249720 ⎘